Pediatric Sleep Research Study @Kovler Diabetes Center

Archive

https://kovlerdiabetescenter.org/portfolio/trialnet-hydroxychloroquine-prevention/ About this Study TrialNet Hydroxychloroquine (HCQ) Prevention is a double-blinded, multicenter, randomized, placebo-controlled trial to determine whether treatment of participants with Stage 1 T1D (2 or more antibodies with normal glucose tolerance) with HCQ results in delay or prevention of progression to Stage 2 T1D (abnormal...

About the Study Researchers in the Endocrinology Division of the University of Chicago are conducting a research study to look at links between home sleep duration/habits and measures of diabetes risk in adolescents. Eligibility Criteria You may be eligible if you are 13-17 years old. What will...

About the study We are currently conducting a clinical research study in kids to look at the safety and effectiveness of a medication approved by the FDA for treatment of type 2 diabetes in adults. Eligibility Criteria If you are 10 to 17 years of age and have...

About the study Researchers in the Endocrinology Division of the University of Chicago are conducting a research study to look at links between sleep problems such as obstructive sleep apnea and Type 2 Diabetes in teens. Eligibility You may be eligible to participate in this study if you...

About the Study: These studies focus on the prevalence, complications of, and best treatments for monogenic diabetes (MODY and neonatal diabetes) through saliva and long-term data collection. Eligibility Criteria: Eligibility determination is made by study staff. Typical inclusion criteria include: diagnosis of diabetes at strong linear family history of...

About this Study The Natural History Study of the Development of type 1 diabetes will study people at increased risk for type 1 diabetes to learn more about how type 1 diabetes occurs. TrialNet is screening close blood relatives of people with type 1 diabetes because relatives...